35756922|t|Whole Exome Sequencing Reveals a Novel APOE Mutation in a Patient With Sporadic Early-Onset Alzheimer's Disease.
35756922|a|Apolipoprotein (APOE) is implicated and verified as the main risk factor for early-onset Alzheimer's disease (AD). APOE is a protein that binds to lipids and is involved in cholesterol stability. Our paper reports a case of a sporadic early-onset AD (sEOAD) patient of a 54-year-old Korean man, where a novel APOE Leu159Pro heterozygous mutation was revealed upon Whole Exome Sequence analysis. The proband's CSF showed downregulated levels of Abeta42, with unchanged Tau levels. The mutation is in the Low-Density Lipoprotein Receptor (LDLR) region of the APOE gene, which mediates the clearance of APOE lipoproteins. LDLR works as a high-affinity point for APOE. Studies suggest that APOE-LDLR interplay could have varying effects. The LDLR receptor pathway has been previously suggested as a therapeutic target to treat tauopathy. However, the APOE-LDLR interaction has also shown a significant correlation with memory retention. Leu159Pro could be an interesting mutation that could be responsible for a less damaging pattern of AD by suppressing tau-association neurodegeneration while affecting the patient's memory retention and cognitive performance.
35756922	39	43	APOE	Gene	348
35756922	58	65	Patient	Species	9606
35756922	92	111	Alzheimer's Disease	Disease	MESH:D000544
35756922	129	133	APOE	Gene	348
35756922	202	221	Alzheimer's disease	Disease	MESH:D000544
35756922	223	225	AD	Disease	MESH:D000544
35756922	228	232	APOE	Gene	348
35756922	260	266	lipids	Chemical	MESH:D008055
35756922	286	297	cholesterol	Chemical	MESH:D002784
35756922	360	362	AD	Disease	MESH:D000544
35756922	364	369	sEOAD	Disease	MESH:D000544
35756922	371	378	patient	Species	9606
35756922	403	406	man	Species	
35756922	422	426	APOE	Gene	348
35756922	427	436	Leu159Pro	ProteinMutation	tmVar:p|SUB|L|159|P;HGVS:p.L159P;VariantGroup:0;CorrespondingGene:348;RS#:1457217956;CorrespondingSpecies:9606
35756922	557	564	Abeta42	Gene	351
35756922	581	584	Tau	Gene	4137
35756922	616	648	Low-Density Lipoprotein Receptor	Gene	3949
35756922	650	654	LDLR	Gene	3949
35756922	670	674	APOE	Gene	348
35756922	713	717	APOE	Gene	348
35756922	732	736	LDLR	Gene	3949
35756922	772	776	APOE	Gene	348
35756922	799	803	APOE	Gene	348
35756922	804	808	LDLR	Gene	3949
35756922	936	945	tauopathy	Disease	MESH:D024801
35756922	960	964	APOE	Gene	348
35756922	965	969	LDLR	Gene	3949
35756922	1046	1055	Leu159Pro	ProteinMutation	tmVar:p|SUB|L|159|P;HGVS:p.L159P;VariantGroup:0;CorrespondingGene:348;RS#:1457217956;CorrespondingSpecies:9606
35756922	1146	1148	AD	Disease	MESH:D000544
35756922	1164	1167	tau	Gene	4137
35756922	1180	1197	neurodegeneration	Disease	MESH:D019636
35756922	1218	1225	patient	Species	9606
35756922	Negative_Correlation	MESH:D019636	RS#:1457217956;HGVS:p.L159P;CorrespondingGene:348
35756922	Association	348	3949
35756922	Positive_Correlation	MESH:D000544	RS#:1457217956;HGVS:p.L159P;CorrespondingGene:348
35756922	Association	MESH:D002784	348
35756922	Association	MESH:D000544	348
35756922	Association	MESH:D019636	4137
35756922	Bind	MESH:D008055	348
35756922	Association	MESH:D019636	348
35756922	Association	MESH:D000544	348

